All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
The Targeted Pulse: Endometrial Cancer Scores Multiple FDA Appr
…
7 months ago
targetedonc.com
The Role of Luspatercept in the Evolving Treatment Landscape of
…
6 days ago
targetedonc.com
An Introduction to Front-line Nivolumab/Ipilimumab Therapy fo
…
3 weeks ago
targetedonc.com
Key Updates from ARMANI in Advanced HER2- Gastric/GEJ Can
…
7 months ago
targetedonc.com
A Need for New Therapies in High-Risk MDS
10 months ago
targetedonc.com
4:36
HER2CLIMB-02: Tucatinib and T-DM1 for Previously Treated HER2
…
Jan 11, 2024
targetedonc.com
Pirtobrutinib as a Game Changer for Patients With CLL
10 months ago
targetedonc.com
Upcoming Insights – Strategies for Management of Dermatological R
…
6 days ago
targetedonc.com
Response to Larotrectinib in NTRK Thyroid Cancer Differs By Subtype
9 months ago
targetedonc.com
3:20
MONARCH 3: First-Line Abemaciclib Plus Nonsteroidal AI
…
Jan 8, 2024
targetedonc.com
Elacestrant as second-line therapy for ESR1-mutated, endocrine-sen
…
1 month ago
targetedonc.com
Key Considerations for the Evolving Treatment Landscape for Relapse
…
3 days ago
targetedonc.com
1:21
Key Takeaways on Recent Data in Breast Cancer from SABCS 2023
Dec 16, 2023
targetedonc.com
Axatilimab in Refractory/Recurrent cGVHD: A Promising Later-Line O
…
4 months ago
targetedonc.com
Efficacy in Platinum-Sensitive vs Platinum-Resistant SCLC
1 month ago
targetedonc.com
2:14
Overview of Radioiodine-Refractory Differentiated Thyroid Cancer (RA
…
Jan 19, 2024
targetedonc.com
Mechanism of Action: Luspatercept vs Epoetin Alfa in LR-MDS
3 months ago
targetedonc.com
Community Oncologists Show Comfort With Bispecifics in B-Cel
…
3 months ago
targetedonc.com
BrECADD Shows Promise as New Standard for Advanced Hodgkin L
…
7 months ago
targetedonc.com
INAVO120: Inavolisib Combination Therapy in PIK3CA-Mutated Breas
…
7 months ago
targetedonc.com
T-DXd Shows Promise in Treating HER2 Breast Cancer With Brain M
…
4 months ago
targetedonc.com
Newly Diagnosed mHSPC: First-Line Treatment Options
3 weeks ago
targetedonc.com
Brain Benefits: Targeted Therapy Offers New Weapon Against HER
…
6 months ago
targetedonc.com
FDA's July 2024 Roundup: Breakthroughs and Milestones in
…
5 months ago
targetedonc.com
Overview of Graft-Versus-Host Disease
4 months ago
targetedonc.com
IO Trials Change Practice in Localized and Metastatic Bladder
…
1 month ago
targetedonc.com
Updated Trial and Real-World Data Show Benefit of Ide-Cel for Multipl
…
11 months ago
targetedonc.com
ESMO 2024: Updates in NIAGARA Study
3 months ago
targetedonc.com
ASH 2024 Preview for Community Oncologists: The Show and After
…
1 month ago
targetedonc.com
The Future of Bispecific Therapy for R/R Multiple Myeloma
3 weeks ago
targetedonc.com
See more videos
More like this
Feedback
Feedback